Podcast # 419: Etripamil

Podcast # 419: Etripamil

Author: Don Stader, MD

Educational Pearls:

  • Etripamil is an intranasal calcium channel blocker in development for use in SVT
  • A recent study showed that etripamil has an SVT conversion rate of around 80%
  • Etripamil does not have the same feeling of "impending doom" that can occur with adenosine

Editor's note: Etripamil is still in development and these results are from a phase II clinical trial.

References:

Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR, Teixeira JM, Bilchick KC, Damle RS, Bernstein RC, Lam WW, O'Neill G, Noseworthy PA, Venkatachalam KL, Coutu B, Mondésert B, Plat F. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol. 2018 Jul 31;72(5):489-497. doi: 10.1016/j.jacc.2018.04.082. PubMed PMID: 30049309.

Summarized by Travis Barlock, MS4 | Edited by Erik Verzemnieks, MD


Jaksot(1154)

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
rss-tiedetta-vai-tarinaa
rss-lihavuudesta-podcast
hippokrateen-vastaanotolla
rss-tervetta-skeptisyytta
utelias-mieli
koodikahvit
rss-duodecim-lehti
rss-astetta-parempi-elama-podcast
rss-metsantuntijat-podcast
university-of-eastern-finland
mielipaivakirja
radio-antro
rss-ranskaa-raakana
rss-ylistys-elaimille
rss-sosiopodi
rss-kasvikutsut
rss-miljonaarien-tasavalta